R-(+)-propranolol targets SOX18 for anti-hemangioma effect independent of beta-blockade
New insights into how specific medicine types treat infant hemangioma growth
This systematic review examines the mechanism of R-(+)-propranolol in infantile hemangioma. It identifies SOX18 as the core molecular target…
A new review shows that one specific form of propranolol may target and shrink baby hemangiomas through a unique pathway.
Oral propranolol remains the primary systemic treatment for infantile hemangioma with no superior alternatives
Propranolol Remains the Standard Treatment for Infantile Hemangioma
This meta-analysis of 2639 patients found that no active intervention, including corticosteroids or other beta-blockers, demonstrated statis…
A review of over 2,600 cases shows that while several drugs treat infantile hemangioma, oral propranolol remains a primary standard.
Review of single-stage surgery for orbital and parasellar infantile hemangioma in a 55-day-old infant
A Baby Had Two Rare Brain Tumors at Once — and Surgeons Removed Both
This case report describes a 55-day-old female infant with orbital and intracranial infantile hemangioma treated via a single-stage left pte…
A 55-day-old baby had two rare brain tumors removed safely in one surgery, resolving eye bulging without neurological damage.